ANEB
Price:
$1.445
Market Cap:
$37.47M
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.[Read more]
Industry
Biotechnology
IPO Date
2021-05-07
Stock Exchange
NASDAQ
Ticker
ANEB
According to Anebulo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.45. This represents a change of -52.36% compared to the average of 7.24 of the last 4 quarters.
The mean historical Current Ratio of Anebulo Pharmaceuticals, Inc. over the last ten years is 31.83. The current 3.45 Current Ratio has changed 983.31% with respect to the historical average. Over the past ten years (40 quarters), ANEB's Current Ratio was at its highest in in the December 2021 quarter at 379.70. The Current Ratio was at its lowest in in the September 2020 quarter at 0.
Average
31.83
Median
21.04
Minimum
13.46
Maximum
82.71
Discovering the peaks and valleys of Anebulo Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 511.40%
Maximum Annual Current Ratio = 82.71
Minimum Annual Increase = -65.68%
Minimum Annual Current Ratio = 13.46
Year | Current Ratio | Change |
---|---|---|
2024 | 13.46 | -36.02% |
2023 | 21.04 | -25.87% |
2022 | 28.39 | -65.68% |
2021 | 82.71 | 511.40% |
The current Current Ratio of Anebulo Pharmaceuticals, Inc. (ANEB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
20.96
5-year avg
31.83
10-year avg
31.83
Anebulo Pharmaceuticals, Inc.’s Current Ratio is greater than Adagene Inc. (2.50), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than AnaptysBio, Inc. (10.23), less than Mineralys Therapeutics, Inc. (8.55), less than Aerovate Therapeutics, Inc. (8.78), greater than Opthea Limited (2.94), less than AN2 Therapeutics, Inc. (9.75), less than PMV Pharmaceuticals, Inc. (0), less than Molecular Partners AG (13.98), less than null (14.33),
Company | Current Ratio | Market cap |
---|---|---|
2.50 | $91.20M | |
12.75 | $199.90M | |
10.23 | $754.94M | |
8.55 | $657.44M | |
8.78 | $77.09M | |
2.94 | $570.92M | |
9.75 | $43.03M | |
0 | $82.28M | |
13.98 | $210.86M | |
14.33 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anebulo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Anebulo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Anebulo Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the highest Current Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 3-year average Current Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
What is the 5-year average Current Ratio for Anebulo Pharmaceuticals, Inc. (ANEB)?
How does the current Current Ratio for Anebulo Pharmaceuticals, Inc. (ANEB) compare to its historical average?